Purificación Estévez-García

Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer

Kathleen N. Moore, Antoine Angelergues, Gottfried E. Konecny et al. · New England Journal of Medicine · 2023 · 414 citations · Full text

Medicine, Oncology, Pharmacology +16

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon et al. · Journal of Clinical Oncology · 2023 · 331 citations · Full text

Medicine, Oncology, Pharmacology +12

Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness

Sandra Muñoz-Galván, Blanca Felipe‐Abrio, Eva M. Verdugo‐Sivianes et al. · Molecular Cancer · 2020 · 121 citations · Full text

Medicine, Cancer Biology, Oncology +17

MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer

Sonia Molina‐Pinelo, Amancio Carnero, Fernando Rivera et al. · BMC Cancer · 2014 · 75 citations · Full text

Medicine, Bioinformatics, Oncology +17

New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools

Sandra Muñoz-Galván, Blanca Felipe‐Abrio, Miguel García-Carrasco et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 41 citations · Full text

Medicine, Bioinformatics, Oncology +17